TNKASE (tenecteplase) - Roche, Boehringer Ingelheim
TNK-FLOW: Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke (clinicaltrials.gov) - Sep 25, 2026 - P2 | N=40 | Enrolling by invitation | Sponsor: Wake Forest University Health Sciences | Trial completion date: Dec 2026 ➔ Jun 2028 | Trial primary completion date: Sep 2026 ➔ Jun 2028 
Trial completion date • Trial primary completion date • Cardiovascular • Ischemic stroke
http://clinicaltrials.gov/ct2/show/NCT06781385
 
Sep 25, 2026
 
Prev Next